Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Revisiting problems and solutions to decrease Mycobacterium tuberculosis pyrazinamide false resistance when using the Bactec MGIT 960 system.

Mustazzolu A, Piersimoni C, Iacobino A, Giannoni F, Chirullo B, Fattorini L.

Ann Ist Super Sanita. 2019 Jan-Mar;55(1):51-54. doi: 10.4415/ANN_19_01_09.

2.

Improved Bactec MGIT 960 Pyrazinamide Test Decreases Detection of False Mycobacterium tuberculosis Pyrazinamide Resistance.

Mustazzolu A, Iacobino A, Giannoni F, Piersimoni C; Italian Multicentre Study on Resistance to Antituberculosis Drugs (SMIRA) Group, Fattorini L.

J Clin Microbiol. 2017 Dec;55(12):3552-3553. doi: 10.1128/JCM.01437-17. Epub 2017 Sep 13. No abstract available.

3.

Pyrazinamide susceptibility testing: proposed new standard with the BACTECTM MGITTM 960 system.

Piersimoni C, Mustazzolu A, Iacobino A, Giannoni F, Santoro G, Gherardi G, Del Giudice A, Perna R, Fattorini L.

Int J Tuberc Lung Dis. 2016 Dec;20(12):1677-1680.

PMID:
27931346
4.

Mycobacterial infections in solid organ transplant recipients.

Meije Y, Piersimoni C, Torre-Cisneros J, Dilektasli AG, Aguado JM; ESCMID Study Group of Infection in Compromised Hosts.

Clin Microbiol Infect. 2014 Sep;20 Suppl 7:89-101. doi: 10.1111/1469-0691.12641. Review.

5.

The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.

Hoefsloot W, van Ingen J, Andrejak C, Angeby K, Bauriaud R, Bemer P, Beylis N, Boeree MJ, Cacho J, Chihota V, Chimara E, Churchyard G, Cias R, Daza R, Daley CL, Dekhuijzen PN, Domingo D, Drobniewski F, Esteban J, Fauville-Dufaux M, Folkvardsen DB, Gibbons N, Gómez-Mampaso E, Gonzalez R, Hoffmann H, Hsueh PR, Indra A, Jagielski T, Jamieson F, Jankovic M, Jong E, Keane J, Koh WJ, Lange B, Leao S, Macedo R, Mannsåker T, Marras TK, Maugein J, Milburn HJ, Mlinkó T, Morcillo N, Morimoto K, Papaventsis D, Palenque E, Paez-Peña M, Piersimoni C, Polanová M, Rastogi N, Richter E, Ruiz-Serrano MJ, Silva A, da Silva MP, Simsek H, van Soolingen D, Szabó N, Thomson R, Tórtola Fernandez T, Tortoli E, Totten SE, Tyrrell G, Vasankari T, Villar M, Walkiewicz R, Winthrop KL, Wagner D; Nontuberculous Mycobacteria Network European Trials Group.

Eur Respir J. 2013 Dec;42(6):1604-13. doi: 10.1183/09031936.00149212. Epub 2013 Apr 18.

6.

Prevention of false resistance results obtained in testing the susceptibility of Mycobacterium tuberculosis to pyrazinamide with the Bactec MGIT 960 system using a reduced inoculum.

Piersimoni C, Mustazzolu A, Giannoni F, Bornigia S, Gherardi G, Fattorini L.

J Clin Microbiol. 2013 Jan;51(1):291-4. doi: 10.1128/JCM.01838-12. Epub 2012 Oct 24.

7.

Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis.

Tortoli E, Russo C, Piersimoni C, Mazzola E, Dal Monte P, Pascarella M, Borroni E, Mondo A, Piana F, Scarparo C, Coltella L, Lombardi G, Cirillo DM.

Eur Respir J. 2012 Aug;40(2):442-7. doi: 10.1183/09031936.00176311. Epub 2012 Jan 12.

8.

Nontuberculous mycobacteria infection in solid organ transplant recipients.

Piersimoni C.

Eur J Clin Microbiol Infect Dis. 2012 Apr;31(4):397-403. doi: 10.1007/s10096-011-1329-4. Epub 2011 Jul 7. Review.

PMID:
21732201
9.

Performance of a commercial nucleic acid amplification test with extrapulmonary specimens for the diagnosis of tuberculosis.

Piersimoni C, Bornigia S, Gherardi G.

Eur J Clin Microbiol Infect Dis. 2012 Mar;31(3):287-93. doi: 10.1007/s10096-011-1309-8. Epub 2011 Jun 24.

PMID:
21701905
10.

Tuberculosis in kindergarten and primary school, Italy, 2008-2009.

Filia A, Ciarrocchi G, Belfiglio R, Caferri M, Bella A, Piersimoni C, Cirillo D, Grilli G, Mancini C, Greco D.

Emerg Infect Dis. 2011 Mar;17(3):514-6. doi: 10.3201/eid1703.101440.

11.

Extrapulmonary infections associated with nontuberculous mycobacteria in immunocompetent persons.

Piersimoni C, Scarparo C.

Emerg Infect Dis. 2009 Sep;15(9):1351-8; quiz 1544. doi: 10.3201/eid1509.081259. Review.

12.

Unreliable detection of Mycobacterium xenopi by the nonradiometric Bactec MGIT 960 culture system.

Piersimoni C, Nista D, Bornigia S, Gherardi G.

J Clin Microbiol. 2009 Mar;47(3):804-6. doi: 10.1128/JCM.01444-08. Epub 2009 Jan 14.

13.

Diagnostic accuracy of in-house PCR for pulmonary tuberculosis in smear-positive patients: meta-analysis and metaregression.

Greco S, Rulli M, Girardi E, Piersimoni C, Saltini C.

J Clin Microbiol. 2009 Mar;47(3):569-76. doi: 10.1128/JCM.02051-08. Epub 2009 Jan 14.

14.

Impact of a chemistry-based DNA extraction method on performance of a commercial amplification assay for detection of Mycobacterium tuberculosis complex.

Piersimoni C, Gherardi G, Nista D, Bornigia S.

J Clin Microbiol. 2009 Jan;47(1):282-3. doi: 10.1128/JCM.00703-08. Epub 2008 Nov 19. No abstract available.

15.

Pulmonary infections associated with non-tuberculous mycobacteria in immunocompetent patients.

Piersimoni C, Scarparo C.

Lancet Infect Dis. 2008 May;8(5):323-34. doi: 10.1016/S1473-3099(08)70100-2. Review.

PMID:
18471777
16.

Validation of the agar proportion and 2 liquid systems for testing the susceptibility of Mycobacterium tuberculosis to moxifloxacin.

Piersimoni C, Lacchini C, Penati V, Iona E, Fattorini L, Nista D, Zallocco D, Gesu GP, Codecasa L.

Diagn Microbiol Infect Dis. 2007 Mar;57(3):283-7.

PMID:
17338942
17.

Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems.

Piersimoni C, Olivieri A, Benacchio L, Scarparo C.

J Clin Microbiol. 2006 Jan;44(1):20-8. Review. No abstract available.

18.

Comparison of tuberculin skin test and Quantiferon immunological assay for latent tuberculosis infection.

Codecasa LR, Ferrarese M, Penati V, Lacchini C, Cirillo D, Scarparo C, Piccoli P, Piersimoni C, Migliori GB.

Monaldi Arch Chest Dis. 2005 Sep;63(3):158-62.

PMID:
16312206
19.

Clinical suspicion as a primary guidance to use commercial amplification tests for rapid diagnosis of pulmonary tuberculosis.

Piersimoni C, Nista D, Zallocco D, Galassi M, Cimarelli ME, Tubaldi A.

Diagn Microbiol Infect Dis. 2005 Nov;53(3):195-200. Epub 2005 Oct 24.

PMID:
16249062
20.

Drug resistance evolution of a Mycobacterium tuberculosis strain from a noncompliant patient.

Meacci F, Orrù G, Iona E, Giannoni F, Piersimoni C, Pozzi G, Fattorini L, Oggioni MR.

J Clin Microbiol. 2005 Jul;43(7):3114-20.

21.

Mycobacterial testing in hospital laboratories: results from a questionnaire survey in Italy.

Piersimoni C, Mandler F, Marchetti D, Molinari GL, Riva R, Tortoli E, Tronci M, Scarparo C.

Clin Microbiol Infect. 2004 Nov;10(11):1014-7.

22.

Mycobacterium triplex pulmonary disease in immunocompetent host.

Piersimoni C, Zitti P, Mazzarelli G, Mariottini A, Nista D, Zallocco D.

Emerg Infect Dis. 2004 Oct;10(10):1859-62. Review.

23.

Mycobacterium lentiflavum as an emerging causative agent of cervical lymphadenitis.

Piersimoni C, Goteri G, Nista D, Mariottini A, Mazzarelli G, Bornigia S.

J Clin Microbiol. 2004 Aug;42(8):3894-7.

24.

Mycobacterium tuberculosis complex drug resistance in Italy.

Migliori GB, Centis R, Fattorini L, Besozzi G, Saltini C, Scarparo C, Cirillo D, Gori A, Cassone A, Piersimoni C.

Emerg Infect Dis. 2004 Apr;10(4):752-3. No abstract available.

25.

Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samples.

Piersimoni C, Scarparo C.

J Clin Microbiol. 2003 Dec;41(12):5355-65. Review. No abstract available.

26.

TB control strategies. Present and future in diagnostic methods: what the clinician can ask to the lab.

Piersimoni C.

Monaldi Arch Chest Dis. 2002 Oct-Dec;57(5-6):306-10. No abstract available.

PMID:
12814047
27.

Mycobacterium celatum pulmonary infection in the immunocompetent: case report and review.

Piersimoni C, Zitti PG, Nista D, Bornigia S.

Emerg Infect Dis. 2003 Mar;9(3):399-402. Review.

28.

Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000.

Migliori GB, Centis R, Fattorini L, Besozzi G, Saltini C, Orefici G, Piersimoni C, Gori A, Cassone A; Italian Multicentre Study on Resistance to Antituberculosis drugs (SMIRA) Study Group.

Eur Respir J. 2003 Jan;21(1):129-34.

29.

Evaluation of the BACTEC MGIT 960 in comparison with BACTEC 460 TB for detection and recovery of mycobacteria from clinical specimens.

Scarparo C, Piccoli P, Rigon A, Ruggiero G, Ricordi P, Piersimoni C.

Diagn Microbiol Infect Dis. 2002 Oct;44(2):157-61.

PMID:
12458122
30.

Performance assessment of two commercial amplification assays for direct detection of Mycobacterium tuberculosis complex from respiratory and extrapulmonary specimens.

Piersimoni C, Scarparo C, Piccoli P, Rigon A, Ruggiero G, Nista D, Bornigia S.

J Clin Microbiol. 2002 Nov;40(11):4138-42.

31.

New N-alkyl-1,2-dihydro-2-thioxo-3-pyridinecarbothioamides as antituberculous agents with improved pharmacokinetics.

Ubiali D, Pagani G, Pregnolato M, Piersimoni C, Pedraz Muñoz JL, Rodríguez Gascón A, Terreni M.

Bioorg Med Chem Lett. 2002 Sep 16;12(18):2541-4.

PMID:
12182855
32.
33.

Mycobacterium doricum sp. nov.

Tortoli E, Piersimoni C, Kroppenstedt RM, Montoya-Burgos JI, Reischl U, Giacometti A, Emler S.

Int J Syst Evol Microbiol. 2001 Nov;51(Pt 6):2007-12.

PMID:
11760941
34.

Direct identification of mycobacteria from MB/BacT alert 3D bottles: comparative evaluation of two commercial probe assays.

Scarparo C, Piccoli P, Rigon A, Ruggiero G, Nista D, Piersimoni C.

J Clin Microbiol. 2001 Sep;39(9):3222-7.

35.

Performance assessment of new multiplex probe assay for identification of mycobacteria.

Tortoli E, Nanetti A, Piersimoni C, Cichero P, Farina C, Mucignat G, Scarparo C, Bartolini L, Valentini R, Nista D, Gesu G, Tosi CP, Crovatto M, Brusarosco G.

J Clin Microbiol. 2001 Mar;39(3):1079-84.

36.

Comparison of MB/Bact alert 3D system with radiometric BACTEC system and Löwenstein-Jensen medium for recovery and identification of mycobacteria from clinical specimens: a multicenter study.

Piersimoni C, Scarparo C, Callegaro A, Tosi CP, Nista D, Bornigia S, Scagnelli M, Rigon A, Ruggiero G, Goglio A.

J Clin Microbiol. 2001 Feb;39(2):651-7.

38.

Synthesis and in vitro anti-mycobacterium activity of N-alkyl-1, 2-dihydro-2-thioxo-3-pyridinecarbothioamides. Preliminary toxicity and pharmacokinetic evaluation.

Pagani G, Pregnolato M, Ubiali D, Terreni M, Piersimoni C, Scaglione F, Fraschini F, Gascón AR, Pedraz Muñoz JL.

J Med Chem. 2000 Jan 27;43(2):199-204.

PMID:
10649975
39.

Activity of 16 antimicrobial agents against drug-resistant strains of Mycobacterium tuberculosis.

Fattorini L, Iona E, Ricci ML, Thoresen OF, Orrù G, Oggioni MR, Tortoli E, Piersimoni C, Chiaradonna P, Tronci M, Pozzi G, Orefici G.

Microb Drug Resist. 1999 Winter;5(4):265-70.

PMID:
10647084
40.

Use of BACTEC MGIT 960 for recovery of mycobacteria from clinical specimens: multicenter study.

Tortoli E, Cichero P, Piersimoni C, Simonetti MT, Gesu G, Nista D.

J Clin Microbiol. 1999 Nov;37(11):3578-82.

41.

Multicenter evaluation of the MB-Redox medium compared with radiometric BACTEC system, mycobacteria growth indicator tube (MGIT), and Löwenstein-Jensen medium for detection and recovery of acid-fast bacilli.

Piersimoni C, Scarparo C, Cichero P, De Pezzo M, Covelli I, Gesu G, Nista D, Scagnelli M, Mandler F.

Diagn Microbiol Infect Dis. 1999 Aug;34(4):293-9.

PMID:
10459480
44.

Multicenter evaluation of mycobacteria growth indicator tube (MGIT) compared with the BACTEC radiometric method, BBL biphasic growth medium and Löwenstein---Jensen medium.

Tortoli E, Mandler F, Tronci M, Penati V, Sbaraglia G, Costa D, Montini G, Predominato M, Riva R, Tosi CP, Piersimoni C, Urbano P.

Clin Microbiol Infect. 1997 Aug;3(4):468-473.

45.

Mycobacterium malmoense in Italy: the modern Norman invasion?

Tortoli E, Piersimoni C, Bartoloni A, Burrini C, Callegaro AP, Caroli G, Colombrita D, Goglio A, Mantella A, Tosi CP, Simonetti MT.

Eur J Epidemiol. 1997 Apr;13(3):341-6.

PMID:
9258535
46.

Characterization of mycobacterial isolates phylogenetically related to, but different from Mycobacterium simiae.

Tortoli E, Piersimoni C, Kirschner P, Bartoloni A, Burrini C, Lacchini C, Mantella A, Muzzi G, Tosi CP, Penati V, Scarparo C, Simonetti MT, Böttger EC.

J Clin Microbiol. 1997 Mar;35(3):697-702.

47.

Isolation of Mycobacterium celatum from patients infected with human immunodeficiency virus.

Piersimoni C, Tortoli E, de Lalla F, Nista D, Donato D, Bornigia S, De Sio G.

Clin Infect Dis. 1997 Feb;24(2):144-7.

PMID:
9114138
48.

Comparative evaluation of two commercial amplification assays for direct detection of Mycobacterium tuberculosis complex in respiratory specimens.

Piersimoni C, Callegaro A, Nista D, Bornigia S, De Conti F, Santini G, De Sio G.

J Clin Microbiol. 1997 Jan;35(1):193-6.

49.

Enteropathogens associated with childhood diarrhea in Italy. The Italian Study Group on Gastrointestinal Infections.

Caprioli A, Pezzella C, Morelli R, Giammanco A, Arista S, Crotti D, Facchini M, Guglielmetti P, Piersimoni C, Luzzi I.

Pediatr Infect Dis J. 1996 Oct;15(10):876-83.

PMID:
8895919
50.

In vitro anti-Mycobacterium avium activity of N-(2-hydroxyethyl)-1,2-benzisothiazol-3(2H)-one and -thione carbamic esters.

Pagani G, Borgna P, Piersimoni C, Nista D, Terreni M, Pregnolato M.

Arch Pharm (Weinheim). 1996 Aug-Sep;329(8-9):421-5.

PMID:
8915105

Supplemental Content

Loading ...
Support Center